enGene Therapeutics (ENGN) Market Capitalization (2022 - 2026)
enGene Therapeutics (ENGN) reported Market Capitalization of $119.96 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 38.1% from $193.69 million a year earlier and down 75.4% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Market Capitalization (2022 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics posted Market Capitalization of $375.05 million, up 12.2% from FY2024.
- Market Capitalization has a three-year compound annual growth rate of 281.4% (FY2022 to FY2025).
- By fiscal year, Market Capitalization came in at $334.37 million in FY2024, $15.02 million in FY2023 (+122.3%) and $6.76 million in FY2022.
- The fiscal Q3 2026 figure ranks as the lowest quarterly Market Capitalization since fiscal Q4 2023.
- Year over year, Market Capitalization gained in four of the last seven quarters, with growth averaging 22.2%.
- The high point for year-over-year Market Capitalization in five years was fiscal Q2 2026 (growth of 130.3%); the low point was fiscal Q2 2025 (a decline of 69.9%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $487.01 million (Q2 2026), $638.41 million (Q1 2026) and $375.05 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | enGene Therapeutics | 104.54 Mn | -889.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 119.96 Mn |
| Apr 30, 2026 | 487.01 Mn |
| Jan 31, 2026 | 638.41 Mn |
| Oct 31, 2025 | 375.05 Mn |
| Jul 31, 2025 | 193.69 Mn |
| Apr 30, 2025 | 211.43 Mn |
| Jan 31, 2025 | 341.55 Mn |
| Oct 31, 2024 | 334.37 Mn |
| Jul 31, 2024 | 420.05 Mn |
| Apr 30, 2024 | 702.12 Mn |
| Jan 31, 2024 | 181.87 Mn |
| Oct 31, 2023 | 15.02 Mn |
| Jul 31, 2023 | 7.57 Mn |
| Apr 30, 2023 | 7.38 Mn |
| Jan 31, 2023 | 6.94 Mn |
| Oct 31, 2022 | 6.76 Mn |
API Access
enGene Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();